The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
US whistleblower Edward Snowden has said becoming an "international fugitive" has been worth it.
London's failed bid to host the 2018 World Cup could be given the kiss of life following the resignation of Fifa boss Sepp Blatter.
Many people suspect that Sepp Blatter stepped down because of a 'smoking gun' - but they may be disappointed, writes Steve Scott.